215 related articles for article (PubMed ID: 15296956)
41. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
Tsai JC; Guy RH; Thornfeldt CR; Gao WN; Feingold KR; Elias PM
J Pharm Sci; 1996 Jun; 85(6):643-8. PubMed ID: 8773963
[TBL] [Abstract][Full Text] [Related]
42. Age-related percutaneous penetration part 2: effect of age on dermatopharmacokinetics and overview of transdermal products.
Konda S; Meier-Davis SR; Cayme B; Shudo J; Maibach HI
Skin Therapy Lett; 2012 Jun; 17(6):5-7. PubMed ID: 22735504
[TBL] [Abstract][Full Text] [Related]
43. Topical and transdermal delivery of caffeine.
Luo L; Lane ME
Int J Pharm; 2015 Jul; 490(1-2):155-64. PubMed ID: 26004004
[TBL] [Abstract][Full Text] [Related]
44. Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations.
Van Gele M; Geusens B; Brochez L; Speeckaert R; Lambert J
Expert Opin Drug Deliv; 2011 Jun; 8(6):705-20. PubMed ID: 21446890
[TBL] [Abstract][Full Text] [Related]
45. An evaluation of mathematical models for predicting skin permeability.
Lian G; Chen L; Han L
J Pharm Sci; 2008 Jan; 97(1):584-98. PubMed ID: 17722002
[TBL] [Abstract][Full Text] [Related]
46. Mathematical models for dermal drug absorption.
Selzer D; Neumann D; Schaefer UF
Expert Opin Drug Metab Toxicol; 2015; 11(10):1567-83. PubMed ID: 26166490
[TBL] [Abstract][Full Text] [Related]
47. Delivering drugs by the transdermal route: review and comment.
Tanner T; Marks R
Skin Res Technol; 2008 Aug; 14(3):249-60. PubMed ID: 19159369
[TBL] [Abstract][Full Text] [Related]
48. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
[TBL] [Abstract][Full Text] [Related]
49. Turning theory into practice: the development of modern transdermal drug delivery systems and future trends.
Perumal O; Murthy SN; Kalia YN
Skin Pharmacol Physiol; 2013; 26(4-6):331-42. PubMed ID: 23921120
[TBL] [Abstract][Full Text] [Related]
50. Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin.
Mutalik S; Udupa N
Pharmazie; 2002 Dec; 57(12):838-41. PubMed ID: 12561248
[TBL] [Abstract][Full Text] [Related]
51. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
[TBL] [Abstract][Full Text] [Related]
52. [Design of transdermal ultrasonophoresis equipment].
Li L; Zhang Y; Li Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Feb; 26(1):184-6. PubMed ID: 19334582
[TBL] [Abstract][Full Text] [Related]
53. Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery.
Wong TW
J Control Release; 2014 Nov; 193():257-69. PubMed ID: 24801250
[TBL] [Abstract][Full Text] [Related]
54. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
55. Skin permeation of ketotifen applied from stick-type formulation.
Kimura C; Nakanishi T; Tojo K
Eur J Pharm Biopharm; 2007 Sep; 67(2):420-4. PubMed ID: 17433642
[TBL] [Abstract][Full Text] [Related]
56. Modelling drug flux through microporated skin.
Rzhevskiy AS; Guy RH; Anissimov YG
J Control Release; 2016 Nov; 241():194-199. PubMed ID: 27686580
[TBL] [Abstract][Full Text] [Related]
57. Finite element modeling of coupled diffusion with partitioning in transdermal drug delivery.
Rim JE; Pinsky PM; van Osdol WW
Ann Biomed Eng; 2005 Oct; 33(10):1422-38. PubMed ID: 16240090
[TBL] [Abstract][Full Text] [Related]
58. Modelling transdermal delivery of high molecular weight drugs from microneedle systems.
Al-Qallaf B; Das DB; Mori D; Cui Z
Philos Trans A Math Phys Eng Sci; 2007 Dec; 365(1861):2951-67. PubMed ID: 17890186
[TBL] [Abstract][Full Text] [Related]
59. Transdermal delivery systems.
Merkle HP
Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):135-53. PubMed ID: 2657273
[TBL] [Abstract][Full Text] [Related]
60. Percutaneous penetration enhancers: an overview.
Thong HY; Zhai H; Maibach HI
Skin Pharmacol Physiol; 2007; 20(6):272-82. PubMed ID: 17717423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
